252 related articles for article (PubMed ID: 15792782)
1. Nicotine and epibatidine alter differently nomifensine-elevated dopamine output in the rat dorsal and ventral striatum.
Janhunen S; Tuominen RK; Piepponen TP; Ahtee L
Eur J Pharmacol; 2005 Mar; 511(2-3):143-50. PubMed ID: 15792782
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of nicotine and epibatidine on the striatal extracellular dopamine.
Janhunen S; Ahtee L
Eur J Pharmacol; 2004 Jun; 494(2-3):167-77. PubMed ID: 15212971
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of epibatidine and nicotine on the output of dopamine in the dorsal and ventral striatum of freely-moving rats.
Seppä T; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 2000 Nov; 362(4-5):444-7. PubMed ID: 11111841
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of nicotine and epibatidine given in combination with nomifensine on rotational behaviour in rats.
Janhunen S; Tuominen RK; Ahtee L
Neurosci Lett; 2005 Jun; 381(3):314-9. PubMed ID: 15896491
[TBL] [Abstract][Full Text] [Related]
5. The effect of nicotine in combination with various dopaminergic drugs on nigrostriatal dopamine in rats.
Janhunen S; Mielikäinen P; Paldánius P; Tuominen RK; Ahtee L; Kaakkola S
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jun; 371(6):480-91. PubMed ID: 16012872
[TBL] [Abstract][Full Text] [Related]
6. Modulation of dopamine release by the nicotinic agonist epibatidine in the frontal cortex and the nucleus accumbens of naive and chronic nicotine treated rats.
Bednar I; Friberg L; Nordberg A
Neurochem Int; 2004 Dec; 45(7):1049-55. PubMed ID: 15337304
[TBL] [Abstract][Full Text] [Related]
7. Selective down-regulation of [(125)I]Y0-alpha-conotoxin MII binding in rat mesostriatal dopamine pathway following continuous infusion of nicotine.
Mugnaini M; Garzotti M; Sartori I; Pilla M; Repeto P; Heidbreder CA; Tessari M
Neuroscience; 2006; 137(2):565-72. PubMed ID: 16289885
[TBL] [Abstract][Full Text] [Related]
8. Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen.
Brazell MP; Mitchell SN; Joseph MH; Gray JA
Neuropharmacology; 1990 Dec; 29(12):1177-85. PubMed ID: 2293060
[TBL] [Abstract][Full Text] [Related]
9. Chronic treatment with a dopamine uptake blocker changes dopamine and acetylcholine but not glutamate and GABA concentrations in prefrontal cortex, striatum and nucleus accumbens of the awake rat.
Hernández LF; Segovia G; Mora F
Neurochem Int; 2008 Feb; 52(3):457-69. PubMed ID: 17881090
[TBL] [Abstract][Full Text] [Related]
10. Loss of nicotinic receptors in monkey striatum after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment is due to a decline in alpha-conotoxin MII sites.
Kulak JM; McIntosh JM; Quik M
Mol Pharmacol; 2002 Jan; 61(1):230-8. PubMed ID: 11752225
[TBL] [Abstract][Full Text] [Related]
11. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation.
You ZB; Chen YQ; Wise RA
Neuroscience; 2001; 107(4):629-39. PubMed ID: 11720786
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous real-time correlation of drug effects on dopamine efflux and uptake in rat striatal slices.
Davidson C; Stamford JA
Biochem Soc Trans; 1993 Nov; 21(4):483S. PubMed ID: 8132050
[No Abstract] [Full Text] [Related]
13. Effects of nicotine and epibatidine on locomotor activity and conditioned place preference in rats.
Janhunen S; Linnervuo A; Svensk M; Ahtee L
Pharmacol Biochem Behav; 2005 Dec; 82(4):758-65. PubMed ID: 16413603
[TBL] [Abstract][Full Text] [Related]
14. Regional differences in the regulation of dopamine and noradrenaline release in medial frontal cortex, nucleus accumbens and caudate-putamen: a microdialysis study in the rat.
Cenci MA; Kalén P; Mandel RJ; Björklund A
Brain Res; 1992 May; 581(2):217-28. PubMed ID: 1393530
[TBL] [Abstract][Full Text] [Related]
15. The effects of acute nicotine on the metabolism of dopamine and the expression of Fos protein in striatal and limbic brain areas of rats during chronic nicotine infusion and its withdrawal.
Salminen O; Seppä T; Gäddnäs H; Ahtee L
J Neurosci; 1999 Sep; 19(18):8145-51. PubMed ID: 10479714
[TBL] [Abstract][Full Text] [Related]
16. Intraaccumbal mecamylamine infusion does not affect dopamine output in the nucleus accumbens of chronically nicotine-treated rats.
Hildebrand BE; Svensson TH
J Neural Transm (Vienna); 2000; 107(8-9):861-72. PubMed ID: 11041268
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine.
Kuczenski R; Segal DS
J Pharmacol Exp Ther; 1992 Sep; 262(3):1085-94. PubMed ID: 1527715
[TBL] [Abstract][Full Text] [Related]
18. Complex I inhibitor effect on the nigral and striatal release of dopamine in the presence and absence of nomifensine.
Santiago M; Granero L; Machado A; Cano J
Eur J Pharmacol; 1995 Jul; 280(3):251-6. PubMed ID: 8566093
[TBL] [Abstract][Full Text] [Related]
19. Regional differences in chronic neuroleptic effects on extracellular dopamine activity.
See RE; Chapman MA; Murray CE; Aravagiri M
Brain Res Bull; 1992; 29(3-4):473-8. PubMed ID: 1382815
[TBL] [Abstract][Full Text] [Related]
20. The effects of systemically administered taurine and N-pivaloyltaurine on striatal extracellular dopamine and taurine in freely moving rats.
Salimäki J; Scriba G; Piepponen TP; Rautolahti N; Ahtee L
Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):134-41. PubMed ID: 12898127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
